Results 191 to 200 of about 634,910 (347)

DNA looping and translocation provide an optimal cleavage mechanism for the type III restriction enzymes

EMBO Journal, 2007
N. Crampton, Stefanie Roes, D. Dryden, D. Rao, J. Edwardson, R. Henderson   +5 more
semanticscholar   +1 more source

CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan   +12 more
wiley   +1 more source

Modified DNA substrate selectivity by GmrSD-family Type IV restriction enzyme BrxU. [PDF]

Philos Trans R Soc Lond B Biol Sci
Readshaw JJ, Lee YJ, Weigele P, Blower TR.   +3 more
europepmc   +1 more source

Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains.

Nucleic Acids Research, 2000
Jeffrey Smith, Marina Bibikova, F. Whitby, Attipalli Ramachandra Reddy, Attipalli Ramachandra Reddy, S. Chandrasegaran, Dana Carroll   +6 more
semanticscholar   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Biology of host-dependent restriction-modification in prokaryotes. [PDF]

EcoSal Plus
Anton BP, Blumenthal R, Eaglesham JB, Mruk I, Roberts RJ, Xu S-y, Weigele PR, Raleigh EA.   +7 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells. [PDF]

Commun Biol
Oliynyk RT, Mahas A, Karpinski E, Church GM.   +3 more
europepmc   +1 more source

Epigenome analysis of an algae-infecting giant virus reveals a unique methylation motif catalogue. [PDF]

PLoS One
Truchon AR, Zinser ER, Wilhelm SW.
europepmc   +1 more source

Evaluation of a Quantitative DNA Methylation Analysis Technique using Methylation-Sensitive/Dependent Restriction Enzymes and Real-Time PCR

Epigenetics, 2006
C. Oakes, S. La Salle, B. Robaire, J. Trasler   +3 more
semanticscholar   +1 more source